CLINICAL_TRIALS
research
· 2016-02-23
Clinical Trial Update: RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC [Phase 3]
Summary
A Phase 3 clinical trial compares adding highly-purified cytotoxic T lymphocytes to radiofrequency ablation versus radiofrequency ablation alone for recurrent h…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ming Kuang | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN